94 related articles for article (PubMed ID: 22824561)
1. Piloting and validating an innovation to triage patients presenting with cough to community pharmacies in Western Australia.
Jiwa M; Hughes J; Sriram D; Birring S; Meng X; Cecchele G; Cooke J; Ng N
Qual Prim Care; 2012; 20(2):83-91. PubMed ID: 22824561
[TBL] [Abstract][Full Text] [Related]
2. Provision of primary care to patients with chronic cough in the community pharmacy setting.
Schneider CR; Everett AW; Geelhoed E; Kendall PA; Murray K; Garnett P; Salama M; Clifford RM
Ann Pharmacother; 2011 Mar; 45(3):402-8. PubMed ID: 21325099
[TBL] [Abstract][Full Text] [Related]
3. Clinical cough IV:what is the minimal important difference for the Leicester Cough Questionnaire?
Raj AA; Pavord DI; Birring SS
Handb Exp Pharmacol; 2009; (187):311-20. PubMed ID: 18825348
[TBL] [Abstract][Full Text] [Related]
4. Do pharmacists know which patients with bowel symptoms should seek further medical advice? A survey of pharmacists practicing in community pharmacy in Western Australia.
Jiwa M; Spilsbury K; Duke J
Ann Pharmacother; 2010 May; 44(5):910-7. PubMed ID: 20371751
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and impact of chronic cough: comparison of specific vs generic quality-of-life questionnaires.
Kalpaklioglu AF; Kara T; Kurtipek E; Kocyigit P; Ekici A; Ekici M
Ann Allergy Asthma Immunol; 2005 May; 94(5):581-5. PubMed ID: 15945562
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a clinical decision-making aid for screening bowel symptoms in community pharmacies.
Sriram D; McManus A; Emmerton L; Parsons R; Jiwa M
J Eval Clin Pract; 2014 Jun; 20(3):260-6. PubMed ID: 24628772
[TBL] [Abstract][Full Text] [Related]
7. Screening for sleep disorders in community pharmacies--evaluation of a campaign in Switzerland.
Hersberger KE; Renggli VP; Nirkko AC; Mathis J; Schwegler K; Bloch KE
J Clin Pharm Ther; 2006 Feb; 31(1):35-41. PubMed ID: 16476118
[TBL] [Abstract][Full Text] [Related]
8. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany.
Berger K; Eickhoff C; Schulz M
J Clin Pharm Ther; 2005 Feb; 30(1):45-57. PubMed ID: 15659003
[TBL] [Abstract][Full Text] [Related]
9. Improvement in health status following bronchopulmonary hygiene physical therapy in patients with bronchiectasis.
Mutalithas K; Watkin G; Willig B; Wardlaw A; Pavord ID; Birring SS
Respir Med; 2008 Aug; 102(8):1140-4. PubMed ID: 18585027
[TBL] [Abstract][Full Text] [Related]
10. [An analysis of factors for quality-of-life in patients with chronic cough].
Shi X; Peng QF; Kong LF
Zhonghua Nei Ke Za Zhi; 2011 Aug; 50(8):672-5. PubMed ID: 22093560
[TBL] [Abstract][Full Text] [Related]
11. A model for assessment and referral of clients with bowel symptoms in community pharmacies.
Sriram D; McManus A; Emmerton LM; Parsons RW; Jiwa M
Curr Med Res Opin; 2016; 32(4):661-7. PubMed ID: 26700973
[TBL] [Abstract][Full Text] [Related]
12. COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study.
Castillo D; Guayta R; Giner J; Burgos F; Capdevila C; Soriano JB; Barau M; Casan P;
Respir Med; 2009 Jun; 103(6):839-45. PubMed ID: 19200706
[TBL] [Abstract][Full Text] [Related]
13. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
[TBL] [Abstract][Full Text] [Related]
14. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study.
Bereznicki B; Peterson G; Jackson S; Haydn Walters E; DeBoos I; Hintz P
J Clin Pharm Ther; 2011 Jun; 36(3):348-55. PubMed ID: 21545614
[TBL] [Abstract][Full Text] [Related]
15. Validation of a parent-proxy quality of life questionnaire for paediatric chronic cough (PC-QOL).
Newcombe PA; Sheffield JK; Juniper EF; Petsky HL; Willis C; Chang AB
Thorax; 2010 Sep; 65(9):819-23. PubMed ID: 20805179
[TBL] [Abstract][Full Text] [Related]
16. A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project.
McNamara KP; O'Reilly SL; Dunbar JA; Bailey MJ; George J; Peterson GM; Jackson SL; Janus ED; Bunker S; Duncan G; Howarth H
Ann Pharmacother; 2012 Feb; 46(2):183-91. PubMed ID: 22318928
[TBL] [Abstract][Full Text] [Related]
17. Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma.
Schneider CR; Everett AW; Geelhoed E; Padgett C; Ripley S; Murray K; Kendall PA; Clifford RM
Ann Pharmacother; 2010; 44(7-8):1319-26. PubMed ID: 20571101
[TBL] [Abstract][Full Text] [Related]
18. Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control.
Armour CL; Lemay K; Saini B; Reddel HK; Bosnic-Anticevich SZ; Smith LD; Burton D; Song YJ; Alles MC; Stewart K; Emmerton L; Krass I
J Asthma; 2011 Nov; 48(9):914-22. PubMed ID: 21942306
[TBL] [Abstract][Full Text] [Related]
19. A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire.
Baiardini I; Braido F; Fassio O; Tarantini F; Pasquali M; Tarchino F; Berlendis A; Canonica GW
Allergy; 2005 Apr; 60(4):482-8. PubMed ID: 15727580
[TBL] [Abstract][Full Text] [Related]
20. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
